Unicycive Therapeutics
UNCY
10 hedge funds and large institutions have $3.02M invested in Unicycive Therapeutics in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.73% more ownership
Funds ownership: 0% → 0.73% (+0.73%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$2.01M |
| 2 |
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
|
+$710K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$74.9K |
| 4 |
Two Sigma Investments
New York
|
+$73.3K |
| 5 |
SMH
Sanders Morris Harris
Houston,
Texas
|
+$57.4K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NCM
1
Nantahala Capital Management
New Canaan,
Connecticut
| $1.98M | +$2.01M | +70,000 | New |
|
|
BOTOTLSJU
2
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
| $700K | +$710K | +24,758 | New |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $73K | +$74.9K | +2,611 | New |
|
|
4
Two Sigma Investments
New York
| $72K | +$73.3K | +2,555 | New |
|
|
SMH
5
Sanders Morris Harris
Houston,
Texas
| $57K | +$57.4K | +2,000 | New |
|
|
FWM
6
Frontier Wealth Management
Kansas City,
Missouri
| $53K | +$54K | +1,884 | New |
|
|
TCM
7
Tandem Capital Management
Woodcliff Lake,
New Jersey
| $44K | +$44.5K | +1,550 | New |
|
8
BlackRock
New York
| $33K | +$32.8K | +1,144 | New |
|
9
UBS Group
Zurich,
Switzerland
| $2K | +$1.78K | +62 | New |
|
10
Wells Fargo
San Francisco,
California
| – | +$86 | +3 | New |
|
UNCY Hedge Fund Activity: Q3 2021 in Review
10 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Unicycive Therapeutics (UNCY) for Q3 2021, worth a combined $3.02M.
Buyers outnumbered sellers: 10 funds opened new UNCY positions and 0 closed out — a net gain of 10 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Nantahala Capital Management, opening a new position worth an estimated $2.01M.
- 10 institutional investors held Unicycive Therapeutics (UNCY) as of Q3 2021, up from 0 in Q2 2021.
- Funds reported $3.02M of Unicycive Therapeutics stock for Q3 2021.
- 10 funds opened new Unicycive Therapeutics positions in Q3 2021 and 0 closed out, a net change of +10 holders.
- The largest Unicycive Therapeutics buyer in Q3 2021 was Nantahala Capital Management, an estimated $2.01M added.
Based on aggregated 13F filings for Q3 2021.